<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25487870</article-id>
      <article-id pub-id-type="pmc">4265405</article-id>
      <article-id pub-id-type="publisher-id">225</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-014-0225-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Karashima</surname>
            <given-names>Takashi</given-names>
          </name>
          <address>
            <email>karasima@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taniguchi</surname>
            <given-names>Yoshinori</given-names>
          </name>
          <address>
            <email>taniguchiy@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shimamoto</surname>
            <given-names>Tsutomu</given-names>
          </name>
          <address>
            <email>jm-tshimamoto@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nao</surname>
            <given-names>Tomoya</given-names>
          </name>
          <address>
            <email>jm-naotomo@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nishikawa</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <address>
            <email>drhiroshi67@extra.ocn.ne.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fukata</surname>
            <given-names>Satoshi</given-names>
          </name>
          <address>
            <email>jm-fukatas@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamada</surname>
            <given-names>Masayuki</given-names>
          </name>
          <address>
            <email>kamadam@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Inoue</surname>
            <given-names>Keiji</given-names>
          </name>
          <address>
            <email>keiji@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oko</surname>
            <given-names>Kentaro</given-names>
          </name>
          <address>
            <email>kentaro-ohko@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakajima</surname>
            <given-names>Hideki</given-names>
          </name>
          <address>
            <email>nakajima@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sano</surname>
            <given-names>Shigetoshi</given-names>
          </name>
          <address>
            <email>sano.derma@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsumoto</surname>
            <given-names>Manabu</given-names>
          </name>
          <address>
            <email>manabu_matumoto@khsc.or.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuroda</surname>
            <given-names>Naoto</given-names>
          </name>
          <address>
            <email>kurochankochi@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamei</surname>
            <given-names>Yoshihiro</given-names>
          </name>
          <address>
            <email>kame.arist8634@docomo.ne.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shuin</surname>
            <given-names>Taro</given-names>
          </name>
          <address>
            <email>shuint@kochi-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Urology, Kochi Medical School, Kohasu, Oko, Nankoku, Kochi 783-8505 Japan </aff>
        <aff id="Aff2"><label/>Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, 783-8505 Japan </aff>
        <aff id="Aff3"><label/>Department of Dermatology, Kochi Medical School, Nankoku, 783-8505 Japan </aff>
        <aff id="Aff4"><label/>Laboratory of Diagnostic Pathology, Kochi Medical School Hospital, Nankoku, 783-8505 Japan </aff>
        <aff id="Aff5"><label/>Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, 780-0062 Japan </aff>
        <aff id="Aff6"><label/>Kamei Private Clinic, Kochi, 780-0085 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>225</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Karashima et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>We report a case of a 33-year-old man who presented with immunoglobulin (Ig)G4-related disease (IgG4-RD) forming a pseudotumor in the left paratesticular region during oral administration of corticosteroid for Wells syndrome, which involves cellulitis with eosinophilia.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>The patient was introduced to our institution from a private hospital with a 3-month history of asymptomatic left scrotal mass. A 5-cm diameter nodule was palpable in the left scrotum. Tumor lesion in the left paratestis involving the epididymis and spermatic cord was observed on computed tomography and magnetic resonance imaging. Blood testing showed no abnormalities other than a minimal increase in C-reactive protein levels. Urine examination likewise revealed no significant findings. Left radical orchidectomy was performed under a diagnosis of left paratesticular neoplasm suspected as malignant tumor. The tumor was pathologically identified as IgG4-RD of the left paratestis involving the epididymis and spermatic cord.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We present a first description of IgG4-RD in a patient with Wells syndrome and the ninth case of IgG4-RD in a scrotal organ, and discuss this very rare entity with reference to the literature.</p>
        </sec>
        <sec>
          <title>Virtual Slides</title>
          <p>The virtual slide(s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_225">http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_225</ext-link></p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>IgG4-related disease</kwd>
        <kwd>Paratestis</kwd>
        <kwd>Pseudotumor</kwd>
        <kwd>Wells syndrome</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Immunoglobulin (Ig)G4-related disease (IgG4-RD) is a recently defined, emerging clinical entity characterized by diffuse fibrosis or mass-forming pseudotumor with infiltration of IgG4-positive plasma cells [<xref ref-type="bibr" rid="CR1">1</xref>]. IgG4-RD often produces a neoplastic entity and has been found in multiple locations throughout the body, including organs of the genitourinary system such as the kidney and prostate. However, only 8 cases of IgG4-RD in the scrotum have been reported to date [<xref ref-type="bibr" rid="CR2">2</xref>-<xref ref-type="bibr" rid="CR6">6</xref>]. We report the ninth case of scrotal pseudotumor associated with IgG4-RD and discuss the clinical and histopathological characteristics of this rare neoplastic entity.</p>
      <p>Wells syndrome is a rare dermatosis, also known as eosinophilic cellulitis, characterized by recurrent inflammatory dermatosis with erythematous plaques [<xref ref-type="bibr" rid="CR7">7</xref>]. We present the first description of IgG4-RD in a patient with Wells syndrome and also discuss the relationship between both of these hyper-immune diseases.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 33-year-old man had noticed swelling with underlying palpable mass in the left scrotum 3&#xA0;months earlier. The patient was introduced to Kochi Medical School from a private hospital on suspicion of testicular cancer. He had taking oral corticosteroid for hyper-eosinophilia diagnosed as Wells syndrome since he was 27&#xA0;years old. He had undergone incisional drainage of a periproctal abscess at 30&#xA0;years old. No history of exposure to tuberculosis was evident. Physical examination revealed a non-tender, indurated, solid mass at the lower pole of the left epididymis, possibly also involving the testis. Scrotal ultrasound demonstrated a solid, heterogeneous mass involving the left epididymis and extending into the testis. Levels of serum tumor markers including &#x3B2;-human chorionic gonadotropin, &#x3B1;-fetoprotein and lactate dehydrogenase were within normal limits. C-reactive protein level was slightly elevated, at 0.5&#xA0;mg/dL (normal, &lt;0.3&#xA0;mg/dL). <italic>Contrast-enhanced computed tomography (CT) of the left scrotum revealed a 31 &#xD7; 28-mm diameter left epididymal mass showing irregular contrast and poorly defined margins.</italic> Magnetic resonance imaging (MRI) of the left scrotum revealed a hypointense mass in the left epididymis on T1- and T2-weighted imaging. Part of the capsule of the left testis showing as a low-intensity layer was poorly marginated on T2 imaging. On diffusion-weighted imaging, the mass showed some high signals (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Left radical orchidectomy was performed under a presumed diagnosis of left paratesticular tumor. The tumor was an elastic, hard, whitish nodule. The origin of the tumor was macroscopically speculated to be the left epididymis, and the part of tumor was unmargined the tunica albuginea and spermatic cord of the left testis (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Pre-operative diagnostic imaging.</bold> Magnetic resonance imaging of the left scrotum shows a low-intensity mass in the paratesticular region on T1 <bold>(A)</bold> -and T2 <bold>(B)</bold> -weighted imaging, and areas of high signals on diffusion-weighted imaging (white arrows; <bold>C</bold>). <italic>The paratesticular lesion is irregularly enhanced on CT imaging</italic>
<bold>(D)</bold>
<italic>. FDG-PET/CT imaging shows accumulation of FDG in left lung</italic>
<bold>(E)</bold>.</p></caption><graphic xlink:href="13000_2014_225_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Macroscopic findings of surgical specimen.</bold> A mass is seen in the tail of the left epididymis, extending to the tunica vaginalis and parenchyma of the left testis (black arrows).</p></caption><graphic xlink:href="13000_2014_225_Fig2_HTML" id="MO2"/></fig></p>
      <p>Histopathology of the tumor demonstrated spindle-shaped epithelial and polygonal cell proliferations with storiform fibrosis. Little atypia and few mitoses were identified among spindle-shaped epithelial cells. Plasmacytes, lymphocytes and eosinophils had infiltrated into the tumor. Typical obstructive phlebitis was also observed. Positive immunostaining was obtained for vimentin, &#x3B1;-smooth muscle actin (&#x3B1;SMA) and desmin (focally), but negative results were seen for CD34, S100 protein, p53, anaplastic lymphoma kinase (ALK), cytokeratin (CAM5.2), calretinin, Wilms&#x2019; tumor-1, thrombomodulin, epithelial membrane antigen and lymphatic endothelial marker in the spindle cells, identifying the myofibroblastic cells. IgG4-positive cells comprised 50% among the cells staining positively for IgG, and the number of IgG4-positive plasma cells/high-power fields (HPF) were more than 10 (Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). The histological finding of pseudotumor was consistent with IgG4-RD in the left epididymis.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Microscopic findings of surgical specimen.</bold> Hematoxylin-eosin staining of the paratesticular mass reveals widespread fibrosis and lymphocyte aggregation from the left epididymis to the spermatic cord (<italic>&#xD7;40;</italic>
<bold>A</bold>). Spindle cell proliferation with chronic inflammatory cells mostly comprised plasma cells with neither atypia nor mitosis (<italic>&#xD7;200;</italic>
<bold>B</bold>). Myofibroblastic cells with marked fibrosis reveals a storiform pattern (<italic>&#xD7;100;</italic>
<bold>C</bold>). Obliterative phlebitis is apparent (<italic>&#xD7;100;</italic>
<bold>D</bold>). <italic>For immunostaining, sections were stained with anti-alpha-smooth muscle actin (&#x3B1;-SMA) (1A4, 1:800, DAKO, Glostrup, Denmark) and -IgG4 (HP6025, 1:1280; ZYMED Laboratories, CA, USA) antibodies by using automated immunostainer (Ventana Benchmark, Tucson, AZ, USA). Spindle cells are positive for &#x3B1;-SMA, indicating myoepithelial cells</italic> (&#xD7;<italic>100;</italic>
<bold>E</bold>)<italic>. More than 10 IgG4-positive plasma cells/HPF are seen on anti-IgG4 immunostaining</italic> (&#xD7;<italic>400;</italic>
<bold>F</bold>)<italic>.</italic>
</p></caption><graphic xlink:href="13000_2014_225_Fig3_HTML" id="MO3"/></fig></p>
      <p>The patient displayed accumulation of <sup>18</sup>&#x2009;F-fluorodeoxyglucose (FDG) in the left lung on FDG-positron emission tomography/CT (FDG-PET/CT) (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>E) after the orchidectomy. The patient has since been continuously taking <italic>1.5&#xA0;mg of oral dexamethasone sodium phosphate equally to 10&#xA0;mg of prednisolone and also to 37.5&#xA0;mg of hydrocrtisone.</italic> The left lung lesion had disappeared on follow-up FDG-PET/CT at 24&#xA0;months postoperatively and no evidence of recurrence was seen at the site of resection.</p>
      <p>We have received a consent from the patient for publication of the present report.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussions</title>
      <p>IgG4-RD is a common autoimmune disease in various organs, including the submandibular gland, lung, pancreas, kidney, retroperitoneum and prostate. IgG-RD often causes pseudotumor consisting of IgG4-positive plasma cell and intense fibrosis. Testis and paratestis with involvement of the epididymis and spermatic cord are rare regions for IgG4-RD. Nine cases, including this case, with scrotal lesions associated with IgG4-RD are summarized in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. Median age was 33&#xA0;years (range, 19&#x2013;74 years). Peak age at onset might show a biphasic pattern, in adolescence and old age. Chief complaints were mostly palpable nodule in the scrotum. Multifocal lesions including in the pancreas, retroperitoneum, submandibular gland and prostate described in Cases 4, 5 and 8 were all in elderly patients at 73, 74 and 64&#xA0;years old, respectively. IgG4-RD in adolescent patients may differ from that in the elderly. <italic>Thirty three years old at the present might be in the elderly case, because he had multi-organ disease including lung lesion on FDG-PET/CT.</italic> All patients underwent surgical excision with orchidectomy or local excision of nodules. Histopathological findings were myofibroblastic proliferation, infiltration of lymphocytes and plasma cells, and a high ratio of IgG4-positive cells.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Brief summary of cases reported in the literature of scrotal IgG4 related pseudotumor</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>
<bold>No.</bold>
</th><th>
<bold>Reference</bold>
</th><th>
<bold>Era</bold>
</th><th>
<bold>Age</bold>
</th><th>
<bold>Presentation</bold>
</th><th>
<bold>Diagnosis and multiorgan disease</bold>
</th><th>
<bold>Treatment</bold>
</th><th>
<bold>Serum IgG4 value (mg/dL)</bold>
</th><th>
<bold>Histology</bold>
</th></tr></thead><tbody><tr valign="top"><td>1</td><td>B&#xF6;sm&#xFC;ller et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>2011</td><td>23</td><td>Bilateral Palpable paratesticular multiple indolent floating masses on both sides</td><td>Paratesticular fibrous pseudotumor</td><td>Surgical excision of nodules</td><td>Not described</td><td>Plasma cell infiltration, IgG4/IgG ratio 44%</td></tr><tr valign="top"><td>2</td><td>B&#xF6;sm&#xFC;ller et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>2011</td><td>25</td><td>Right swelling of the right testis with pain</td><td>Paratesticular inflammatory pseudotumor</td><td>Semicastration.</td><td>Not described</td><td>Dense myofibroblastic proliferation with sparse mitoses, IgG4/IgG ratio 48%</td></tr><tr valign="top"><td>3</td><td>B&#xF6;sm&#xFC;ller et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>2011</td><td>52</td><td>Right palpable paratesticular nodules</td><td>Paratesticular fibrous pseudotumor</td><td>Surgical excision of nodules</td><td>Not described</td><td>Plasma cell infiltration, IgG4/IgG ratio 46%</td></tr><tr valign="top"><td>4</td><td>Hart et al. [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>2012</td><td>73</td><td>Painless right scrotal mass</td><td>Paratesticular pseudotumor, Autoimmune pancreatitis, Retroperitoneal fibrosis</td><td>Right inguinal radical orchiectomy</td><td>391</td><td>Lymphoplasmacytic infiltration, storiform pattern of fibrosis, IgG4/IgG ratio 60%</td></tr><tr valign="top"><td>5</td><td>Migita et al. [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>2012</td><td>74</td><td>Left paratesticular mass</td><td>Paratesticular pseudotumor, Submandibular gland inflammation, prostatitis</td><td>Left semicastration</td><td>505</td><td>Fibrosis with lymphocytic and plasmacytic infiltrations, IgG4/IgG ratio 85%</td></tr><tr valign="top"><td>6</td><td>Dickmann et al. [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>2013</td><td>19</td><td>Right painless intrascrotal mass</td><td>Spermatic cord inflammatory pseudotumor</td><td>Local excision</td><td>Not determined</td><td>Partially storiform, spindle-like cells and lymphofollicular infiltration, IgG4/IgG ratio 40%</td></tr><tr valign="top"><td>7</td><td>Dickmann et al. [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>2013</td><td>28</td><td>Right painless intrascrotal mass</td><td>Spermatic cord inflammatory pseudotumor</td><td>Local excision</td><td>Not determined</td><td>As above</td></tr><tr valign="top"><td>8</td><td>de Buy Wenniger et al. [<xref ref-type="bibr" rid="CR6">6</xref>]</td><td>2013</td><td>64</td><td>Bilateral scrotal pain</td><td>Testicular pseudotumor, Autoimmune pancreatitis, Retroperitoneal fibrosis</td><td>Bilateral orchidectomy</td><td>Not described</td><td>Plasma cell-rich infiltrate and myofibroblastic spindle cell proliferation around the seminiferous tubules, IgG4/IgG ratio 50% in right testis and 80% in left testis</td></tr><tr valign="top"><td>9</td><td>Our case</td><td>2014</td><td>33</td><td>Left palpable scrotal mass</td><td>Paratesticular pseudotumor, Lung lesion</td><td>Radical orchidectomy</td><td>31.8</td><td>Spindle epithelial and polygonal cell proliferation with intense fibrous, plasmacyte, lymphocyte and eosinophil infiltration, IgG4/IgG ratio 50%</td></tr></tbody></table></table-wrap></p>
      <p>Comprehensive diagnostic criteria for IgG4-RD were described in 2011, setting the following 3 criteria: 1) clinical examination showing characteristic diffuse/localized swelling or masses in single or multiple organs; 2) hematological examination showing elevated serum IgG4 concentrations (&gt;135&#xA0;mg/dl); and 3) histopathological examination showing marked lymphocyte and plasmacyte infiltration and fibrosis, and infiltration of IgG4-positive plasma cells (ratio of IgG4-positive/IgG-positive cells &gt;40% and &gt;10 IgG4-positive plasma cells/HPF) [<xref ref-type="bibr" rid="CR8">8</xref>]. The present case was identified as &#x201C;probable&#x201D;, meeting criteria 1 and 3. Serum IgG4 concentration in our patient was 31.8&#xA0;mg/dl before surgery. The patient had receiving oral administration of corticosteroid, which might have decreased serum IgG4 concentrations to within normal limits. As the patient had a history of developing dyspnea and cyanosis due to upper airway edema when not taking corticosteroid, the patient has continued taking corticosteroid.</p>
      <p><italic>Various differential diagnoses show inflammation-related tumors involving true or pseudo-neoplasia.</italic> Inflammatory pseudotumor related to microbial infection, trauma or postoperative status must be diagnosed by excluding other possibilities. In the present case, histopathological findings of less mitotic myofibroblastic proliferation with storiform and swirling fibrosis, lymphoplasmacytic infiltration, obliterative phlebitis and an abundance of IgG4-positive cells met the criteria allowing final diagnosis of pseudotumor associated with IgG4-RD. Immunomarkers offered additional definitive and exclusive diagnosis of IgG4-RD. In the present case, the differential diagnosis should have included inflammatory myofibroblastic tumor (IMT), a typical neoplastic entity with positive immunostaining of ALK. Staining for vimentin and &#x3B1;SMA was diffusely positive and desmin was focally positive, but negative results were seen for CD34, S100 protein, p53 and ALK in the present case, indicating myoepithelial cell proliferation and excluding neoplasias such as IMT. However, consideration should be given to the fact that cases of scrotal IMT have been reported to often show negative immunostaining for ALK [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>Wells syndrome is an uncommon inflammatory dermatosis, first described in 1971 by Wells. Clinical appearance is variable, combined with the histopathological presence of eosinophilic infiltrates and flame figures in the absence of vasculitis, and a relapsing remitting course is usually seen. The present case was diagnosed as Wells syndrome based on systemic cellulitis combined with histopathological presence of eosinophilic infiltration of the skin 6&#xA0;years earlier. A case with hypereosinophilic syndrome was reported with overlapping IgG4-RD in 2012. The author implied that hypereosinophilic syndrome interacted with IgG4-RD [<xref ref-type="bibr" rid="CR10">10</xref>]. In Wells syndrome, an eosinophilic infiltration mediated by T-helper cells 2 cytokines such as interleukin-5 and &#x2212;13 is based on immune-pathogenesis in common with IgG4-RD [<xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>]. Histopathological findings for the skin lesion showed features as eosinophilic infiltration common with the paratesticular lesion, <italic>but not positive immunostaining with anti-IgG4 antibody in the present case. A common immune-etiology of Wells syndrome and IgG4-RD were still controversial.</italic></p>
      <p>In the literature, not all patients could be diagnosed preoperatively because of the lack of characteristic findings for scrotal IgG4-RD. Our patient also underwent radical orchidectomy, even though CT, MRI and biological testing were performed. Orchidectomy should be avoided for pseudotumor associated with IgG4-RD and pharmacotherapy such as corticosteroid and immunosuppressive agents should be applied instead.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>The paratestis is a clinically rare region for IgG4-RD. We have reported a case of IgG4-RD of the paratestis in a patient treated with corticosteroid for Wells syndrome, a systemic eosinophilic disease.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>IgG4-RD</term>
            <def>
              <p>IgG4-related disease</p>
            </def>
          </def-item>
          <def-item>
            <term>CT</term>
            <def>
              <p>Contrast-enhanced computed tomography</p>
            </def>
          </def-item>
          <def-item>
            <term>MRI</term>
            <def>
              <p>Magnetic resonance imaging</p>
            </def>
          </def-item>
          <def-item>
            <term>&#x3B1;SMA</term>
            <def>
              <p>&#x3B1;-smooth muscle actin</p>
            </def>
          </def-item>
          <def-item>
            <term>ALK</term>
            <def>
              <p>Anaplastic lymphoma kinase</p>
            </def>
          </def-item>
          <def-item>
            <term>HPF</term>
            <def>
              <p>High-power fields</p>
            </def>
          </def-item>
          <def-item>
            <term>FDG-PET</term>
            <def>
              <p><sup>18</sup>&#x2009;F-fluorodeoxyglucose-positron emission tomography</p>
            </def>
          </def-item>
          <def-item>
            <term>IMT</term>
            <def>
              <p>Inflammatory myofibroblastic tumor</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>TK drafted the report, contributed to concept, and cared for the patient. TS, TN, HN, SF, MK, KI and YK cared for the patient. YT, NK and TS contributed to concept and design, and approved the final version of the manuscript. KO, HN, SS and MM made relevant corrections. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umehara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sumida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mimori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsubota</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Takegami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tomosugi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kurose</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ishigaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Azumi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>D</given-names>
            </name>
            <collab>Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team</collab>
          </person-group>
          <article-title>A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details</article-title>
          <source>Mod Rheumatol</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.3109/s10165-011-0508-6</pub-id>
          <pub-id pub-id-type="pmid">21881964</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>B&#xF6;sm&#xFC;ller</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>von Weyhern</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Adam</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alibegovic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mikuz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fend</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Paratesticular fibrous pseudotumor&#x2013;an IgG4-related disorder?</article-title>
          <source>Virchows Arch</source>
          <year>2011</year>
          <volume>458</volume>
          <issue>1</issue>
          <fpage>109</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-010-0995-4</pub-id>
          <pub-id pub-id-type="pmid">20957491</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Moyer</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Hogan</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Chari</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease</article-title>
          <source>Hum Pathol</source>
          <year>2012</year>
          <volume>43</volume>
          <issue>11</issue>
          <fpage>2084</fpage>
          <lpage>2087</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2012.05.017</pub-id>
          <pub-id pub-id-type="pmid">22974477</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Migita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyashita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jiuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takeoka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nishino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease</article-title>
          <source>Mod Rheumato</source>
          <year>2014</year>
          <volume>24</volume>
          <issue>1</issue>
          <fpage>188</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.3109/14397595.2013.852841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dieckmann</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Struss</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nahler-Wildenhain</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Paratesticular fibrous pseudotumor in young males presenting with histological features of IgG4-related disease: two case reports</article-title>
          <source>J Med Case Rep</source>
          <year>2013</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>225</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-1947-7-225</pub-id>
          <pub-id pub-id-type="pmid">24025610</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Buy Wenniger</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Scheltema</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Verheij</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Beuers</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Testicular inflammation as a new manifestation of IgG4-associated disease</article-title>
          <source>Urology</source>
          <year>2013</year>
          <volume>82</volume>
          <issue>2</issue>
          <fpage>e15</fpage>
          <lpage>e16</lpage>
          <pub-id pub-id-type="doi">10.1016/j.urology.2013.04.046</pub-id>
          <pub-id pub-id-type="pmid">23896119</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haddad</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>TN</given-names>
            </name>
          </person-group>
          <article-title>Wells syndrome</article-title>
          <source>Cutis</source>
          <year>2014</year>
          <volume>93</volume>
          <fpage>38</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umehara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hamano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kamisawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimosegawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimatsu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Notohara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sumida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mimori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chiba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mishima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hibi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsubouchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Inui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)</article-title>
          <source>Mod Rheumatol</source>
          <year>2012</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>21</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.3109/s10165-011-0571-z</pub-id>
          <pub-id pub-id-type="pmid">22218969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dangle</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Pohar</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory myofibroblastic tumor of epididymis: a case report and review of literature</article-title>
          <source>World J Surg Oncol</source>
          <year>2008</year>
          <volume>6</volume>
          <fpage>119</fpage>
          <pub-id pub-id-type="doi">10.1186/1477-7819-6-119</pub-id>
          <pub-id pub-id-type="pmid">19014442</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A patient with hypereosinophilic syndrome that manifested with acquired hemophilia and elevated IgG4: a case report</article-title>
          <source>J Med Case Rep</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>63</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-1947-6-63</pub-id>
          <pub-id pub-id-type="pmid">22333532</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Notohara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related disease: historical overview and pathology of hematological disorders</article-title>
          <source>Pathol Int</source>
          <year>2010</year>
          <volume>60</volume>
          <issue>4</issue>
          <fpage>247</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.2010.02524.x</pub-id>
          <pub-id pub-id-type="pmid">20403026</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Espa&#xF1;a</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sanz</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Sola</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Wells&#x2019; syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5</article-title>
          <source>Br J Dermatol</source>
          <year>1999</year>
          <volume>140</volume>
          <issue>1</issue>
          <fpage>127</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2133.1999.02621.x</pub-id>
          <pub-id pub-id-type="pmid">10215782</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
